All Stories

  1. The virulence domain of Shigella IcsA contains a subregion with specific host cell adhesion function
  2. Mutational analysis of the major periplasmic loops of Shigella flexneri Wzy: identification of the residues affecting O antigen modal chain length control, and Wzz-dependent polymerization activity
  3. Lipopolysaccharide surface structure does not influence IcsA polarity
  4. Mutational Analysis of the Shigella flexneri O-Antigen Polymerase Wzy: Identification of Wzz-Dependent Wzy Mutants
  5. Topology of Streptococcus pneumoniae CpsC, a Polysaccharide Copolymerase and Bacterial Protein Tyrosine Kinase Adaptor Protein
  6. Tyrosine phosphorylation enhances activity of pneumococcal autolysin LytA
  7. Progress in understanding the assembly process of bacterial O-antigen
  8. Myosin IIA is essential for Shigella flexneri cell-to-cell spread
  9. Dynamin-related protein Drp1 and mitochondria are important for Shigella flexneri infection
  10. The Role of Bacterial Protein Tyrosine Phosphatases in the Regulation of the Biosynthesis of Secreted Polysaccharides
  11. Molecular Basis for O-Antigen Biosynthesis in Vibrio cholerae O1: Ogawa-Inaba Switching
  12. IcsA Is a Shigella flexneri Adhesin Regulated by the Type III Secretion System and Required for Pathogenesis
  13. Relationship between O-antigen chain length and resistance to colicin E2 in Shigella flexneri
  14. Impact of Dynasore an Inhibitor of Dynamin II on Shigella flexneri Infection
  15. Complete Genome Sequence of SfII, a Serotype-Converting Bacteriophage of the Highly Prevalent Shigella flexneri Serotype 2a
  16. Asymmetric localisation of IcsP
  17. Encapsulating Bacteria
  18. Residues located inside the Escherichia coli FepE protein oligomer are essential for lipopolysaccharide O-antigen modal chain length regulation
  19. Identification of Shigella flexneri IcsA Residues Affecting Interaction with N-WASP, and Evidence for IcsA-IcsA Co-Operative Interaction
  20. Dual inhibition of DNA polymerase PolC and protein tyrosine phosphatase CpsB uncovers a novel antibiotic target
  21. Absence of O antigen suppresses Shigella flexneri IcsA autochaperone region mutations
  22. Escherichia coli 83972 Expressing a P fimbriae Oligosaccharide Receptor Mimic Impairs Adhesion of Uropathogenic E. coli
  23. Wzy-Dependent Bacterial Capsules as Potential Drug Targets
  24. Bioengineered microbes in disease therapy
  25. Chemical Inhibition of Bacterial Protein Tyrosine Phosphatase Suppresses Capsule Production
  26. Self-association of the Shigella flexneri IcsA autotransporter protein
  27. 5-Benzylidenerhodanine and 5-benzylidene-2-4-thiazolidinedione based antibacterials
  28. IcsA autotransporter passenger promotes increased fusion protein expression on the cell surface
  29. Identification of Streptococcus pneumoniae Cps2C Residues That Affect Capsular Polysaccharide Polymerization, Cell Wall Ligation, and Cps2D Phosphorylation
  30. Designer Probiotics and Enteric Cytoprotection
  31. Receptor-mimic probiotics: potential therapeutics for bacterial toxin-mediated enteric diseases
  32. Mutagenesis and Chemical Cross-Linking Suggest that Wzz Dimer Stability and Oligomerization Affect Lipopolysaccharide O-Antigen Modal Chain Length Control
  33. Bioengineered bugs expressing oligosaccharide receptor mimics: Toxin-binding probiotics for treatment and prevention of enteric infections
  34. Differential immunogenicity of Vibrio cholerae O139 variants expressing different combinations of naturally occurring and atypical forms of the serogroup polysaccharide
  35. Sequence-structure relationships in polysaccharide co-polymerase (PCP) proteins
  36. Mutagenesis of the Shigella flexneri Autotransporter IcsA Reveals Novel Functional Regions Involved in IcsA Biogenesis and Recruitment of Host Neural Wiscott-Aldrich Syndrome Protein
  37. Coiled-coil regions play a role in the function of the Shigella flexneri O-antigen chain length regulator WzzpHS2
  38. Bacterial polysaccharide co-polymerases share a common framework for control of polymer length
  39. Attachment of capsular polysaccharide to the cell wall of Streptococcus pneumoniae type 2 is required for invasive disease
  40. A Recombinant Probiotic for Treatment and Prevention of Cholera
  41. Altering the Length of the Lipopolysaccharide O Antigen Has an Impact on the Interaction of Salmonella enterica Serovar Typhimurium with Macrophages and Complement
  42. Role of oxyR in the Oral Anaerobe Porphyromonas gingivalis
  43. Designer probiotics for prevention of enteric infections
  44. Inducible serum resistance in Salmonella typhimurium is dependent on wzzfepE-regulated very long O antigen chains
  45. Recombinant Probiotics for Treatment and Prevention of Enterotoxigenic Escherichia coli Diarrhea
  46. Topological analysis of GtrA and GtrB proteins encoded by the serotype-converting cassette of Shigella flexneri
  47. The Effect That Mutations in the Conserved Capsular Polysaccharide Biosynthesis Genes cpsA, cpsB, and cpsD Have on Virulence of Streptococcus pneumoniae
  48. The Chromosome of Shigella flexneri Bacteriophage Sf6: Complete Nucleotide Sequence, Genetic Mosaicism, and DNA Packaging
  49. Refinement of a Therapeutic Shiga Toxin–Binding Probiotic for Human Trials
  50. The actin-based motility defect of a Shigella flexneri rmlD rough LPS mutant is not due to loss of IcsA polarity
  51. Mutational Analysis of the Carboxy-Terminal (YGX)4 Repeat Domain of CpsD, an Autophosphorylating Tyrosine Kinase Required for Capsule Biosynthesis in Streptococcus pneumoniae
  52. Lipopolysaccharide O antigen chains mask IcsA (VirG) in Shigella flexneri
  53. Multicopy icsA is able to suppress the virulence defect caused by the wzz SF mutation in Shigella flexneri
  54. Genetic modulation of Shigella flexneri 2a lipopolysaccharide O antigen modal chain length reveals that it has been optimized for virulence
  55. Regulation of Salmonella typhimurium lipopolysaccharide O antigen chain length is required for virulence; identification of FepE as a second Wzz
  56. The Tailspike Protein of Shigella Phage Sf6: A STRUCTURAL HOMOLOG OF SALMONELLA PHAGE P22 TAILSPIKE PROTEIN WITHOUT SEQUENCE SIMILARITY IN THE  -HELIX DOMAIN
  57. Epitope analysis of the FanC subunit protein of the K99 (F5) fimbriae of enterotoxigenic Escherichia coli using a recombinant fusion technique
  58. Tyrosine phosphorylation of CpsD negatively regulates capsular polysaccharide biosynthesis in Streptococcus pneumoniae
  59. Streptococcus pneumoniae Capsule Biosynthesis Protein CpsB Is a Novel Manganese-Dependent Phosphotyrosine-Protein Phosphatase
  60. Neutralization of Shiga Toxins Stx1, Stx2c, and Stx2e by Recombinant Bacteria Expressing Mimics of Globotriose and Globotetraose
  61. Oral Administration of Formaldehyde-Killed Recombinant Bacteria Expressing a Mimic of the Shiga Toxin Receptor Protects Mice from Fatal Challenge with Shiga-ToxigenicEscherichia coli
  62. Analysis of Shigella flexneri Wzz (Rol) function by mutagenesis and cross-linking: Wzz is able to oligomerize
  63. The Shigella flexneri bacteriophage Sf6 tailspike protein (TSP)/endorhamnosidase is related to the bacteriophage P22 TSP and has a motif common to exo- and endoglycanases, and C-5 epimerases
  64. Molecular and genetic characterization of the capsule biosynthesis locus of Streptococcus pneumoniae type 23F
  65. The Salmonella typhi melittin resistance gene pqaB affects intracellular growth in PMA-differentiated U937 cells, polymyxin B resistance and lipopolysaccharide
  66. Overexpression and topology of the Shigella flexneri O-antigen polymerase (Rfc/Wzy)
  67. Recombinational exchanges at the capsular polysaccharide biosynthetic locus lead to frequent serotype changes among natural isolates ofStreptococcus pneumoniae
  68. Mechanism of bacteriophage SfII‐mediated serotype conversion in Shigella flexneri
  69. PhoP/Q regulated genes inSalmonella typhi: identification of melittin sensitive mutants
  70. Characterization of the locus encoding the Streptococcus pneumoniae type 19F capsular polysaccharide biosynthetic pathway
  71. Regulation of O‐antigen chain length is required for Shigella flexneri virulence
  72. Characterization of the Capsular Polysaccharide Biosynthesis Locus of Streptococcus pneumoniae Type 19F
  73. A putative pathway for perosamine biosynthesis is the first function encoded within the rfb region of Vibrio cholerae O1
  74. A putative pathway for biosynthesis of the O-antigen component, 3-deoxy-L-glycero-tetronic acid, based on the sequence of the Vibrio cholerae 01 rfb region
  75. Genetic rearrangements in the rfb regions of Vibrio cholerae O1 and O139.
  76. Lipopolysaccharide with an altered O-antigen produced inEscherichia coliK-12 harbouring mutated, clonedShigella flexneri rfbgenes
  77. Release of chloramphenicol acetyl transferase from recombinant Escherichia coli by sonication and the French press
  78. Genetic analysis of the rfbX gene of shigella flexneri
  79. In vibrio cholerae serogroup O 1, rfaD is closely linked to the rfb operon
  80. Putative O-antigen transport genes within the rfb region of Vibrio cholerae O1 are homologous to those for capsule transport
  81. Construction of K88- and K99-expressing clones of Salmonella typhimurium G30: immunogenicity following oral administration to pigs
  82. Characterization of the dTDP-rhamnose biosynthetic genes encoded in the rfb iocus of Shigella flexneri
  83. Immunization of mice with Salmonella typhimurium C5 aroA expressing a genetically toxoided derivative of the pneumococcal toxin pneumolysin
  84. 5110588 Composite salmonella E. coli, vibrio cholerae vaccine strainsRenato Morona, Stephen R Attridge, Aberfoyle Park, Australia assigned to Enterovax Limited
  85. Serotype conversion in Vibrio cholerae O1.
  86. Biosynthesis of the lipopolysaccharides of Vibrio cholerae 01 and generation of O-antigen serotype specificity
  87. Construction of plasmid vectors with a non-antibiotic selection system based on the Escherichia coli thyA+ gene: application to cholera vaccine development
  88. Effect of lipopolysaccharide core synthesis mutations on the production of Vibrio cholerae O-antigen in Escherixhia coli K-12
  89. Effect of lipopolysaccharide core synthesis mutations on the production of Vibrio cholerae O-antigen in Escherixhia coli K-12
  90. Genetic analysis of the rfb region of Shigella flexneri encoding the Y serotype O-antigen specificity
  91. Regions of the cloned Vibrio cholerae rfb genes needed to determine the Ogawa form of the O-antigen
  92. Surface co-expression of Vibrio cholerae and Salmonella typhi O-antigens on Ty21a clone EX210
  93. Immunogenicity of a Candidate Live Oral Typhoid/Cholera Hybrid Vaccine in Humans
  94. Towards a live oral vaccine against enterotoxigenic Escherichia coli of swine
  95. Contruction of Defined galE Mutants of Salmonella for Use as Vaccines
  96. A physical map of the chromosomal region determining O-antigen biosynthesis in Vibrio cholerae 01
  97. Detection of an OmpA-like protein in Vibrio cholerae
  98. The nature of ompA mutants of Escherichia coli K12 exhibiting temperature-sensitive bacteriophage resistance
  99. Demonstration of a bacteriophage receptor site on the Escherichia coli K12 outer-membrane protein OmpC by the use of a protease
  100. Detection of several diisopropylfluorophosphate-binding proteins in the outer membrane of Escherichia coli K-12
  101. Detection of several diisopropylfluorophosphate-binding proteins in the outer membrane of Escherichia coli K-12
  102. A new locus, stc, which affects the phenotype of tolC mutants of Escherichia coli K-12
  103. Molecular cloning of the tolC locus of Escherichia coli K-12 with the use of transposon Tn10